The GENetic Frontotemporal Dementia Initiative (GENFI): a new multi-centre platform for the study of frontotemporal lobar degeneration

Martin Rossor (MRC), Giovanni B. Frisoni (MDS), Mario Masellis (CIHR)

Recent advances in molecular biology and neuropathology of frontotemporal lobar degeneration (FTLD) have yet to be translated into effective, disease-modifying therapies. Further progress toward this goal will depend on largescale collaborative efforts that harness resources and expertise across specialist centres. The proposed programme will develop and evaluate the feasibility of a platform for mounting future large-scale natural history studies of FTLD and for conducting clinical trials of disease-modifying interventions.

Welcome to our website, here you can inform yourself basically cookie-free.

We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.

Your browser allows the setting of cookies: